App-Quantinova.ai

ASC Methylation and Expression are Associated with Depressive Symptoms, Anxiety, and Quality of Life in Heart Failure

Brittany Butts - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

Women-s Experiences Being Diagnosed with Peripartum Cardiomyopathy

Rebecca L. Dekker - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Contemporary Natural History, Mechanical Circulatory Support Needs and Post-Transplant Outcomes of Patients With Myocarditis Listed for Heart Transplantation.

Chantal Elamm - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Central-Line Associated Bloodstream Infections Related to Inpatient Pulmonary Artery Catheterization Among Patients Waiting for Heart Transplantation

Usama Daimee - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Heart muscle disease

N/A

Burden of Heart Failure and Treatment Practices Among Patients with HIV Infection in an Era of Contemporary Antiretroviral Therapy

Sadeer G. Al-Kindi - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Heart muscle disease

hydrocortisone + gentamicin

Right Ventricular Stroke Work Index is Inversely Related to Renal Function in Patients with Left Ventricular Diastolic Heart Failure

Qaiser Shafiq - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Features of Transthyretin Cardiomyopathy Patients With 6 Specific Cardiac Genotypes in the THAOS Registry.

Jennifer Schumacher - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

Mofezolac

Dilated Cardiomyopathy Causes Significant Derangement in Biventricular Mechanics Not Fully Appreciated By Simply Measuring Left Ventricular Ejection Fraction Alone

Francisco Lopez-Menendez - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Impact of Pre-transplant Cirrhotic Cardiomyopathy on Long-Term Mortality in the Liver Recipients

Thoetchai Peeraphatdit - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Predictive Value of 1, 25-dihydroxyvitamin D to PTH(1-84) Ratios for Cardiovascular Death in Heart Failure

Damien Gruson - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Parathyroid hormone

The Presence of IgG3 Autoantibody Against ?1 Adrenergic Receptors is Associated with Favorable Myocardial Recovery in Patients with Recent Onset Cardiomyopathy - a Post-hoc Analysis of IMAC-2 Study

Yuji Nagatomo - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Hypoxia Inducible Factor (HIF) Adaptation After Mechanical Circulatory Unloading of the Heart. A Gene Expression Analysis Study of Paired Myocardial Samples

Paulino Alvarez - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Baseline Pulmonary Function and Outcomes in Patients Receiving Left Ventricular Assist Devices

Suraj Raheja - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Reversibility of Restrictive Pulmonary Function Post Cardiac Transplantation

Carolyn M. Rosner - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Heart muscle disease

N/A

HeartMate II to HVAD Device Exchange: What Can We Learn?

Kershaw V. Patel - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Arrhythmic Outcomes in Patients following Explanation of Left Ventricular Assist Devices after Myocardial Recovery

Amaninderapal S. Ghotra - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Increased risk of Cerebrovascular Death in Patients with Chemotherapy-Induced Cardiomyopathy

Emile Mehanna - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Heart muscle disease

N/A

Pediatric Versus Adult Heart Failure Related Emergency Department Visits in the United States

Joseph W. Rossano - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Constrictive Pericarditis in a Post Cardiac Transplant Patient

Ugochukwu O. Egolum - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Heart muscle disease

N/A

Incremental Diagnostic and Clinical Utility of Endomyocardial Biopsy Over Cardiac Magnetic Resonance Imaging Alone in Patients with Unexplained Heart Failure

Nisha A. Gilotra - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Heart muscle disease

Mofezolac

Filters

3340 Abstracts